Trading / Browse Companies / Neurelis stock

Neurelis Stock

www.neurelis.comBioTechFounded: 2007Funding to Date: $247.94MM

Neurelis is a neuroscience company focusing on the development and commercialization of product candidates for epilepsy and the broader central nervous system market.

Buy or sell Neurelis stock
OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Neurelis, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Other companies like Neurelis in the BioTech sector

Mammoth Biosciences
Sector
BioTech
Last Round Est. Valuation
$1.08B
Ginkgo Bioworks
Sector
BioTech
Last Round Est. Valuation
$4.89B
PROCEPT BioRobotics
Sector
BioTech
Last Round Est. Valuation
$872.62MM
Synthego
Sector
BioTech
Last Round Est. Valuation
$486.63MM
eFFECTOR Therapeutics
Sector
BioTech
Last Round Est. Valuation
$186.12MM
Human Longevity
Sector
BioTech
Last Round Est. Valuation
$50.4MM
Grail
Sector
BioTech
Last Round Est. Valuation
$4.26B
Arsenal Biosciences
Sector
BioTech
Last Round Est. Valuation
$185MM
Caris Life Sciences
Sector
BioTech
 
 

Trending Companies

Frequently Asked Questions